Categories: News

KARL STORZ unifies its US organizations under a central management team, Sonal Matai named US President

Enhanced organizational structure will drive innovation and improve engagement with and delivery of excellence to KARL STORZ customers, accelerating growth




EL SEGUNDO, Calif.–(BUSINESS WIRE)–KARL STORZ, a leading family-owned medical technology company, today announced it will centralize management of its United States organizations, including its research and development, manufacturing, and commercial operations, to bring more innovative products to market worldwide with greater speed. Sonal Matai, who has led the US commercial business for two years, has been named President of KARL STORZ in the United States and will lead the effort to bring this ambitious transformation to life.

“The US is the world’s largest medical device market and also the largest market for KARL STORZ,” said Sonal Matai, US President of KARL STORZ. “Our 2,700 employees in the United States can now work together more closely to create an enhanced customer experience in this critical geography through innovative products and superior service.”

“Our new organizational structure will bring benefits to all our stakeholders. Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the US,” Matai added.

Matai was previously Managing Director, KARL STORZ Endoscopy-America, Inc. In that role, he spearheaded a period of significant innovation and market share expansion. His prior leadership experiences at large MedTech companies and start-ups, as well as his global outlook and dedication to innovation and customer satisfaction, have honed his ability to drive progress and steer market leadership.

About KARL STORZ

KARL STORZ United States is a leader in endoscopic technology and imaging solutions across virtually all surgical specialties. It is a subsidiary of KARL STORZ SE & Co. KG, an international medical technology company that is family-owned and based in Tuttlingen, Germany. KARL STORZ stands for visionary design, precision craftsmanship, and clinical effectiveness and has a portfolio that includes more than 15,000 products for human and veterinary medicine.

Contacts

MEDIA CONTACT:

Susan Mancia

Director, Integrated Marketing Communications

KARL STORZ United States

Phone: 562-841-1515

Email: susan.mancia@karlstorz.com

Staff

Recent Posts

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

23 minutes ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

1 hour ago

Mexico’s EHR Revolution: Driving Digital Health Innovation and Market Growth, Insights From Black Book Research

Key Trends, Vendor Performance, and Opportunities Transforming Mexico's Healthcare IT Landscape MIAMI, FLORIDA / ACCESSWIRE…

1 hour ago

Rapid Dose Announces Proposed Issuance of Shares as Payment of Director Fees

Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…

4 hours ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…

4 hours ago

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused…

4 hours ago